Back
Paris
WeeklyBUY
Long termOWN
DSY.
DSY.PA
DASSAULT SYSTEMES

Latest update

$18.99

Updated: Apr 28, 2026, 2:09 PM UTC

Browsing public data

Metrics

Loading fundamentals

Pulling sales, cash, and growth data for DSY.PA.

Thesis

Why this read

This is a tactical, lower-confidence timing call on short-term mean reversion within a damaged intermediate structure. The 20-day momentum bounce and daily EMA hold offer a contained-risk entry, but revenue decline and weak relative strength make this a trade, not a long-term position. Fundamentals are deteriorating—forward earnings estimates are compressing, not expanding—and any weekly close below $18.20 invalidates the thesis quickly. I am explicitly not claiming the business is healthy; I am claiming the risk/reward for a 2-4 week bounce is asymmetric at this level with earnings 87 days away.

Short-term thesis

Aligned50% conviction-2 ptsv1
Own it, but wait for a better window

The long-term case survives, but the entry does not need to happen right now.

Long-term exposure

Own

The business backdrop is strong enough for long-term exposure.

Entry window

Wait

The setup is fighting relative strength, so patience still matters.

Risk check

Fragile

The downside can widen quickly if this setup goes wrong.

Alignment

Aligned

The weekly setup and the long-term case are pulling together.

What supports it

  • Sales and cash still support a long hold.
  • Price still looks reasonable against the business.
  • Balance sheet gives the thesis room to breathe.
  • Debt service still looks controlled against cash generation.

What limits it

  • This needs smaller size or more patience.
  • The stock is trailing its sector by 9.9 points.
  • Analyst revisions have been net negative over the past month.
  • Weekly 21 EMA at $20.50 rejected price twice; sustained downtrend on higher timeframe intact

Long-term thesis

Dassault Systèmes sits at the intersection of industrial digitalization and sustainability mandates—its 3DEXPERIENCE platform enables virtual twins that slash physical prototyping waste while accelerating product cycles for aerospace, automotive, and life sciences customers spending hundreds of billions on compliance-driven reinvention.

62opportunity
Crossing Chasm5y horizon

Demand Gap

Current installed base of virtual twin deployments covers perhaps 15-20% of addressable industrial R&D spend; regulatory-driven timeline compressions (2030 emissions deadlines, 2027 EU DPP requirements) suggest 3-4x expansion needed in simulation and PLM capacity by 2029

Dependency Chain

  1. 1If EU Green Deal and IRA decarbonization enforcement intensify, physical product testing must collapse into simulation → Dassault's virtual twin IP is the dominant software layer
  2. 2If pharma/biotech R&D productivity crisis deepens, molecular simulation and clinical trial virtualization becomes mandatory → BIOVIA and Medidata integration captures this
  3. 3If defense spending reaccelerates globally, sovereign manufacturing autonomy requires digital thread mastery → CATIA and ENOVIA are embedded in Airbus, Boeing, Safran supply chains

Must be true

  • Enterprise customers accept platform consolidation around 3DEXPERIENCE rather than point-solution fragmentation from Autodesk, Siemens, or cloud-native entrants
  • Cloud transition and SaaS pricing stick without the margin compression that plagued Adobe's early shift
  • China+1 reshoring keeps Western manufacturing工程设计 relevant rather than ceding to domestic Chinese PLM

Thesis broken if

  • Two consecutive quarters of declining CATIA/ENOVIA recurring revenue growth below 5% in constant currency, suggesting platform fatigue rather than transition noise
  • Major OEM (Boeing, Volkswagen tier-1) announces wholesale shift to Siemens Xcelerator or Autodesk Fusion for core CAD/PLM

History

Analysis timeline
1 runs

Jan 21, 1970

Latest

Updated Apr 28, 2026, 2:09 PM UTC

WeeklyBUY
Long termOWN
Confidence52% · Low

Price at review

$18.99

Price has reclaimed the daily 21 EMA and is grinding in a tight range beneath weekly resistance at $20.50. This is a tactical setup for a potential markup continuation toward $21-22 if volume confirms, but the weekly downtrend structure remains unresolved.